Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
Abingworth, Abraxane, accretion, adenocarcinoma, Aetna, aflibercept, AHZANTIVE, AKS, ALVAIZ, Amarin, andcorporate, ankylosing, Antikickback, antipsychotic, APA, arbitrary, Aria, atypical, averting, BaNefesh, BCPIA, breast, Bridion, Bright, burden, BV, campaign, cancer, cardiovascular, Carlo, Carlyle, CGCP, CGLP, chemotherapy, Chevron, Children, Chinese, confirmatory, constantly, contrary, Corcept, Cushing, Dakota, DARI, David, deadline, dealing, deepfake, deforestation, degeneration, degradation, depletion, Depot, developmental, Dimethyl, divisional, doctrine, documentsand, duvakitug, EBA, eculizumab, educational, engineering, Enlarged, Entyvio, EPYSQLI, ethyl, expedited, exploiting, FCA, FCDA, FDCA, ff, Fingolimod, fiscalyear, formation, formula, Formycon, globe, glycemic, Glycerol, gMG, Haarlem, harnessing, hemoglobinuria, hemolytic, holistic, HRSA, icosapent, idiopathic, illicit, image, imprisonment, inconsistent, inflammation, inOctober, Inspector, Ireland, JKI, jointly, judicial, juvenile, Korlym, Laboratory, LAR, Lastly, licensure, lifted, liraglutide, LLP, London, longstanding, Loper, lung, mAbxience, macular, McAvoy, memorandum, Metaplim, MHRA, mifepristone, moderate, momentum, Monte, MSP, multifaceted, myasthenia, nAMD, neovascular, nocturnal, nurse, OCR, OIG, opt, outpace, paroxysmal, partly, Phenylbutyrate, phishing, pill, plain, plaque, PNH, polyfluoroalkyl, PREMIERProRx, prepay, presumption, prone, psoriatic, push, QMS, Quallent, Raimondo, Ravicti, recuse, relocated, remeasured, renamed, retinal, revert, rheumatoid, rolled, route, Samsung, SELARSDI, SELARSDITM, sham, SIMLANDI, simulation, simultaneously, Soul, stifle, Sugammadex, Sulfamethoxazole, Sunshine, suppurativa, surety, Switzerland, TAPI, teaching, theCivil, Trimethoprim, Tysabri, unconstitutional, underwritten, Unified, unitary, UPC, uremic, Vascepa, vedolizymab, vial, Victoza, voice, wastewater, witha
Removed:
acquirer, actuarial, adalimumab, affirmance, aggregated, agonist, airway, Alzheimer, Amgen, amounting, appellate, Asian, biotechnological, border, bronchodilator, bronchospasm, building, capture, carbamazepine, CAUTIONARY, centered, cerebral, chose, cinacalcet, colchicine, Constitution, Cooperation, corticosteroid, diet, Digihaler, dosing, downgrade, downgraded, emerge, endeavor, entail, ER, etodolac, existence, exiting, feedback, finalization, fixing, fluocinonide, frame, historic, holding, House, ICS, improved, LLC, MDI, mediation, MERGE, mission, module, mount, multigenerational, nadolol, nuevo, ointment, oriented, Otsuka, output, Pacific, palsy, participant, Peruvian, Pharmascience, pioglitazone, pretrial, promoting, protested, rating, recognizing, refractory, remanded, renewed, restriction, reversible, sartan, Sensipar, sol, systemic, temozolomide, trastuzumab, travel, TRISENOX, twenty, uncontrolled, undertaken, vacated, victory, vulnerability, warfarin, wave
Filing tables
Filing exhibits
Related press release
TEVA similar filings
Filing view
External links